Next Article in Journal
Effect of Aminated Chitosan-Coated Fe3O4 Nanoparticles with Applicational Potential in Nanomedicine on DPPG, DSPC, and POPC Langmuir Monolayers as Cell Membrane Models
Next Article in Special Issue
Myosin Phosphatase Is Implicated in the Control of THP-1 Monocyte to Macrophage Differentiation
Previous Article in Journal
Comparison of the Efficacy of Two Novel Antitubercular Agents in Free and Liposome-Encapsulated Formulations
Previous Article in Special Issue
Growth Factors VEGF-A165 and FGF-2 as Multifunctional Biomolecules Governing Cell Adhesion and Proliferation
 
 
Review
Peer-Review Record

Nutraceuticals in the Prevention of Viral Infections, including COVID-19, among the Pediatric Population: A Review of the Literature

Int. J. Mol. Sci. 2021, 22(5), 2465; https://doi.org/10.3390/ijms22052465
by Giuseppe Fabio Parisi 1, Giuseppe Carota 2, Carlo Castruccio Castracani 3, Mariarita Spampinato 2, Sara Manti 1, Maria Papale 1, Michelino Di Rosa 2, Ignazio Barbagallo 4,* and Salvatore Leonardi 1
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Int. J. Mol. Sci. 2021, 22(5), 2465; https://doi.org/10.3390/ijms22052465
Submission received: 27 January 2021 / Revised: 24 February 2021 / Accepted: 25 February 2021 / Published: 28 February 2021
(This article belongs to the Special Issue 25th Anniversary of IJMS: Advances in Biochemistry)

Round 1

Reviewer 1 Report

This is a very interesting and well-written review. Attention to the following issues would further strengthen the present manuscript:

  • Line 52, second page. Please add have ALSO been reported
  • Regarding probiotics, please add some important drawbacks particularly in immunocompromised individuals ( PMID: 32472285, PMID: 31729330, PMID: 33005864, etc)
  • A table is necessary presenting clinical studies or meta-analyses (study, number of participants, type of study, effects, limitations) related to nutraceuticals and COVID-19 particularly related to vitamin D, C, A, Omega-3 (Ω-3) Fatty Acids etc.
  • Also for the readership, it would be imperative to modify Table #1 with all these nutraceuticals in a column, in vitro effects regarding other viruses, in vitro effects regarding SARS-CoV-2, and in vivo effects. As it is, Table 1 is not specific and not helpful.
  • Please analyze in depth after presenting Table (issue#3) the effect of vitamin D on the risk of infection, severity of COVID-19, risk of hospitalization, mechanical ventilation and mortality. There are a couple of meta-analyses dealing with this subject. After that, discuss the effect of supplementation with vitamin D. What are the proposed concentrations of vitamin D that are considered optimal for prevention of severe COVID-19? Please discuss also the role of the Mediterranean diet in vitamin D levels (PMID: 32429342; PMID: 33509003). This is an important issue relating anti-inflammatory diet and vitamin D levels.
  • Regarding zinc, please refer also to studies using zinc together with hydroxychloroquine in COVID-19.
  • Regarding vitamin A, please discuss the potential of hepatotoxicity with its administration.
  • It is important to include immune-boosting nutraceuticals such as curcumin, bromelain (PMID: 33291560, PMID: 33205039, PMID: 33133525)

Author Response

Reviewer 1

This is a very interesting and well-written review. Attention to the following issues would further strengthen the present manuscript:

 

Line 52, second page. Please add have ALSO been reported

Answer: Thank you. We added “also”.

Regarding probiotics, please add some important drawbacks particularly in immunocompromised individuals ( PMID: 32472285, PMID: 31729330, PMID: 33005864, etc)

Answer: Thank you for your suggestion. We added some drawbacks about immunocompromised individuals.

A table is necessary presenting clinical studies or meta-analyses (study, number of participants, type of study, effects, limitations) related to nutraceuticals and COVID-19 particularly related to vitamin D, C, A, Omega-3 (Ω-3) Fatty Acids etc.

Answer: Thank you for your suggestion. As you requested, we modified and implemented table 1 with your required info.

 

Also for the readership, it would be imperative to modify Table #1 with all these nutraceuticals in a column, in vitro effects regarding other viruses, in vitro effects regarding SARS-CoV-2, and in vivo effects. As it is, Table 1 is not specific and not helpful.

Answer: Thank you. As you suggested, we modified table 1. 

Please analyze in depth after presenting Table (issue#3) the effect of vitamin D on the risk of infection, severity of COVID-19, risk of hospitalization, mechanical ventilation and mortality. There are a couple of meta-analyses dealing with this subject. After that, discuss the effect of supplementation with vitamin D. What are the proposed concentrations of vitamin D that are considered optimal for prevention of severe COVID-19? Please discuss also the role of the Mediterranean diet in vitamin D levels (PMID: 32429342; PMID: 33509003). This is an important issue relating anti-inflammatory diet and vitamin D levels.

Answer: Thank you. As you suggested, we further expanded the vitamin D section. 

 

Regarding zinc, please refer also to studies using zinc together with hydroxychloroquine in COVID-19.

Answer: Thank you. As you suggested, we also evaluated the synergistic action between zinc and hydroxychloroquine.  

 

Regarding vitamin A, please discuss the potential of hepatotoxicity with its administration.

Answer: Thank you. As you suggested, we discussed about potential of hepatotoxicity with vitamin A administration.

 

 

 

It is important to include immune-boosting nutraceuticals such as curcumin, bromelain (PMID: 33291560, PMID: 33205039, PMID: 33133525)

Answer: Thank you. As you required, we added your suggestions in discussion section. 

Reviewer 2 Report

Parisi and colleagues want to summarize, by a review of the literature, the role of nutraceuticals in viral infections and COVID-19 infection, with a special attention to children.

The aim of the work is relevant and interesting, but the manuscript need to improve in ordered to be accepted.

In attached the authors could find a PDF file with my comments highlighted in the text. Moreover below some further comments are reported:

  1. In general I found that paragraphs don't follow all the same structure. For instance, explanation of the molecule in the immune system; studies that reported this evidence; role and studies in children should be expected in each of the section dedicated to the single molecule. Some of them (ex. Zinc) don't have comments about children. I believe that even when no data on studies on children are found,it should be reported since it is claimed as the aim of the study. The same goes for COVID-19. Moreover for some nutraceutics a lot of information is reported, in some case even too much (not relevant for the aim of the work) while for others, a lot of information is missing. What I expect to find in a review, is a clear presentation on the studies  that have been investigated the topic, and I could find it for all the molecules.
  2. I believe that the paragraph dedicated to vitamine D should be arranged in a clearer way, and I suggest to add some systematic-review/meta-analysis among the listed studies.
  3. Table and Figures on the contrary are clear and well-done
  4. I found the Conclusion paragraph not clear, this probably due to a wrong order in which the paragraphs are presented.

 

Comments for author File: Comments.pdf

Author Response

Reviewer 2

Parisi and colleagues want to summarize, by a review of the literature, the role of nutraceuticals in viral infections and COVID-19 infection, with a special attention to children.

The aim of the work is relevant and interesting, but the manuscript need to improve in ordered to be accepted.

In attached the authors could find a PDF file with my comments highlighted in the text. Moreover below some further comments are reported:

In general I found that paragraphs don't follow all the same structure. For instance, explanation of the molecule in the immune system; studies that reported this evidence; role and studies in children should be expected in each of the section dedicated to the single molecule. Some of them (ex. Zinc) don't have comments about children. I believe that even when no data on studies on children are found,it should be reported since it is claimed as the aim of the study. The same goes for COVID-19. Moreover for some nutraceutics a lot of information is reported, in some case even too much (not relevant for the aim of the work) while for others, a lot of information is missing. What I expect to find in a review, is a clear presentation on the studies  that have been investigated the topic, and I could find it for all the molecules.

Answer: Dear reviewer, thank you for your suggestions. We tried to review the manuscript following the same structure for each paragraph: 1) molecule characteristics; 2) actions on the immune system; 3) specific evidences on SARS-CoV2 infections; 4) specific evidences in children. When evidences are lacking, we stated that in the text. We have also edited the manuscript following the corrections suggested by your pdf file.

 

I believe that the paragraph dedicated to vitamine D should be arranged in a clearer way, and I suggest to add some systematic-review/meta-analysis among the listed studies.

Answer: Thank you. We revised vitamin D section and we expanded it.

 

Table and Figures on the contrary are clear and well-done

Answer: Thank you. We modified and implemented table 1 with clinical evidence.

I found the Conclusion paragraph not clear, this probably due to a wrong order in which the paragraphs are presented.

Answer: Thank you. The conclusions section focuses heavily on the clinical repercussions of the reported scientific evidence. We tried to revised that paragraph trying to make it clearer.

Round 2

Reviewer 2 Report

I thank the authors to address in a proper way all my comments. They did a lot of effort to improve their manuscript.

I don't have any further comments.

Back to TopTop